Rice Hall James & Associates’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.12M | Sell |
|
|||||
|
2022
Q2 | $8.12M | Sell |
|
|||||
|
2022
Q1 | $12.4M | Sell |
|
|||||
|
2021
Q4 | $14.9M | Sell |
|
|||||
|
2021
Q3 | $18.6M | Sell |
|
|||||
|
2021
Q2 | $25.7M | Sell |
|
|||||
|
2021
Q1 | $46.9M | Sell |
|
|||||
|
2020
Q4 | $52.7M | Sell |
|
|||||
|
2020
Q3 | $64.4M | Sell |
|
|||||
|
2020
Q2 | $52.4M | Sell |
|
|||||
|
2020
Q1 | $44.3M | Sell |
|
|||||
|
2019
Q4 | $59.4M | Sell |
|
|||||
|
2019
Q3 | $64.2M | Buy |
|
|||||
|
2019
Q2 | $58.1M | Sell |
|
|||||
|
2019
Q1 | $61.7M | Sell |
|
|||||
|
2018
Q4 | $80.4M | Buy |
|
|||||
|
2018
Q3 | $73.5M | Sell |
|
|||||
|
2018
Q2 | $57.6M | Buy |
|
|||||
|
2018
Q1 | $50.9M | Buy |
|
|||||
|
2017
Q4 | $35.7M | Buy |
|
|||||
|
2017
Q3 | $26M | Sell |
|
|||||
|
2017
Q2 | $22.7M | Buy |
|
|||||
|
2017
Q1 | $15.4M | Buy |
|
|||||
|
2016
Q4 | $12.8M | Buy |
|
|||||
|
2016
Q3 | $9.92M | Buy |
|
|||||
|
2016
Q2 | $7.85M | Buy |
|
|||||
|
2016
Q1 | $10M | Buy |
|
|||||
|
2015
Q4 | $10.8M | Buy |
|
|||||
|
2015
Q3 | $4.41M | Buy |
|
|||||
|
2015
Q2 | $3.04M | Buy |
|